Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Pharmacology & Therapeutics|April 30, 2016
MicroRNAs and drug-induced kidney injuryMira Pavkovic, Vishal S VaidyaToxicology|June 1, 2014
Urinary microRNA profiling for identification of biomarkers after cisplatin-induced kidney injuryMira Pavkovic, Björn Riefke, Heidrun Ellinger-ZiegelbauerJournal of Pharmacological and Toxicological Methods|December 17, 2013
Comparison of the MesoScale Discovery and Luminex multiplex platforms for measurement of urinary biomarkers in a cisplatin rat kidney injury modelMira Pavkovic, Björn Riefke, Katrin Gutberlet, et al.Genomics Data|December 24, 2015
Glomerulonephritis-induced changes in kidney gene expression in ratsMira Pavkovic, Björn Riefke, Anna-Lena Frisk, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|March 12, 2015
Glomerulonephritis-Induced Changes in Urinary and Kidney MicroRNA Profiles in RatsMira Pavkovic, Björn Riefke, Anna-Lena Frisk, et al.Toxicology|May 23, 2017
Quantitative targeted bile acid profiling as new markers for DILI in a model of methapyrilene-induced liver injury in ratsMarkus Slopianka, Anne Herrmann, Mira Pavkovic, et al.American Journal of Nephrology|September 13, 2021
Direct Blood Pressure-Independent Anti-Fibrotic Effects by the Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone in Progressive Models of Kidney FibrosisKaroline Droebner, Mira Pavkovic, Manuel Grundmann, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|March 4, 2022
Urinary miRNA Profiles in Chronic Kidney Injury-Benefits of Extracellular Vesicle Enrichment and miRNAs as Potential Biomarkers for Renal Fibrosis, Glomerular Injury, and Endothelial DysfunctionBarbara Petzuch, Agnès Bénardeau, Lucas Hofmeister, et al.Journal of the American Society of Nephrology : JASN|January 21, 2026
Single-Cell Resolution Drug Effects of Renin-Angiotensin-Aldosterone Blockade in ZSF1 Rat Diabetic Kidney DiseaseMichael S Balzer, Jianfu Zhou, Amin Abedini, et al.American Journal of Nephrology|June 10, 2021
Effects of Finerenone Combined with Empagliflozin in a Model of Hypertension-Induced End-Organ DamagePeter Kolkhof, Elke Hartmann, Alexius Freyberger, et al.Pageof 3